カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

核医学/放射性医薬品の世界市場予測（～2023年）

【英語タイトル】Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

MarketsandMarketsが出版した調査資料（PH-3590）・商品コード：PH-3590
・発行会社（調査会社）：MarketsandMarkets
・発行日：2018年6月14日
・ページ数：214
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥734,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥864,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,059,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
MarketsandMarketsが発行した当調査レポートでは、核医学/放射性医薬品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類（診断、治療）別分析、用途別分析、地域別分析、核医学/放射性医薬品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・核医学/放射性医薬品の世界市場：市場インサイト
・核医学/放射性医薬品の世界市場：市場概観/市場動向
・核医学/放射性医薬品の世界市場：市場シェア分析
・核医学/放射性医薬品の世界市場：種類（診断、治療）別分析/市場規模
・核医学/放射性医薬品の世界市場：用途別分析/市場規模
・核医学/放射性医薬品の世界市場：地域別分析/市場規模
・核医学/放射性医薬品のアジア市場規模予測
・核医学/放射性医薬品のヨーロッパ市場規模予測
・核医学/放射性医薬品のアメリカ市場規模予測
・核医学/放射性医薬品の世界市場動向
・核医学/放射性医薬品の世界市場：競争状況
・核医学/放射性医薬品の世界市場：関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018 at a CAGR of 5.9%. The major influencing factors driving the growth of this market are the increasing incidence and prevalence of target conditions and initiatives to lessen the demand-supply gap of Mo-99.
By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine. The diagnostic segment is further segmented into SPECT and PET radiopharmaceuticals. The SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, and others. The PET radiopharmaceuticals include F-18, Ru-82, and others. The therapeutic segment is further segmented into beta emitters, alpha emitters, and brachytherapy. The diagnostic segment accounted for the largest share of the nuclear medicine market, primarily due to the use of the diagnostic radiopharmaceutical Tc-99m which is used in a majority of nuclear medicine procedures.

Based on applications, the nuclear medicine market is segmented into diagnostic and therapeutic applications. The diagnostic applications are further segmented into SPECT applications and PET applications. Whereas the therapeutic applications are further segmented into thyroid, bone metastasis, lymphoma, endocrine tumors, and others (breast cancer, cervical cancer, GI tumors, and renal tumors). The SPECT application segment accounted for the largest share of the diagnostic nuclear medicine market by applications owing to the rising demand for cardiac imaging.

Based on procedural volume, the nuclear medicine market is segmented into volumes for diagnostic and therapeutic procedures. The diagnostic procedures market is segmented into procedural volumes of SPECT and PET radiopharmaceuticals. The therapeutic procedures market is segmented into procedural volumes beta emitters, alpha emitters, and brachytherapy isotopes. Tc-99m accounted for the largest number of procedures performed in the nuclear medicine market as it has a longer half-life and is easy to transport as compared to other radiopharmaceuticals.

Nuclear Medicine/Radiopharmaceuticals Market

By region, the global market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the research initiatives in Japan, rising installations of PET scanners in India and China owing to technological advancement, and initiatives taken by the Australian government.

Factors such as short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are expected to limit the growth of the market to a certain extent.

The major market players in the nuclear medicine market include Cardinal Health (US), GE Healthcare (US), and Curium (France). Other players involved in this market are Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India). Other players in the nuclear medicine market include Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India).

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 34)
4.1 Nuclear Medicine: Market Overview
4.2 Geographic Analysis: Nuclear Medicine Market for Pet Applications, By Type (2017)
4.3 Nuclear Medicine Market Share, By Type, 2018 vs 2023
4.4 Geographical Snapshot of the Nuclear Medicine Market

5 Market Overview (Page No. – 38)
5.1 Introduction
5.1.2 Market Dynamics
5.1.3 Drivers
5.1.3.1 Increasing Incidence and Prevalence of Target Conditions
5.1.3.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.1.3.3 Initiatives to Lessen the Demand-Supply Gap of Mo-99
5.1.4 Restraints
5.1.4.1 Short Half-Life of Radiopharmaceuticals
5.1.5 Opportunities
5.1.5.1 Use of Radiopharmaceuticals in Neurological Applications
5.1.6 Challenges
5.1.6.1 Hospital Budget Cuts and High Equipment Prices

6 Nuclear Medicine/Radiopharmaceuticals Market, By Type (Page No. – 42)
6.1 Introduction
6.2 Diagnostic Nuclear Medicine
6.2.1 Spect Radiopharmaceuticals
6.2.1.1 Tc-99m
6.2.1.2 Tl-201
6.2.1.3 Ga-67
6.2.1.4 I-123
6.2.1.5 Other Spect Isotopes
6.2.2 Pet Radiopharmaceuticals
6.2.2.1 F-18
6.2.2.2 Ru-82
6.2.2.3 Other Pet Isotopes
6.3 Therapeutic Nuclear Medicine
6.3.1 Alpha Emitters
6.3.1.1 Ra-223
6.3.2 Beta Emitters
6.3.2.1 I-131
6.3.2.2 Y-90
6.3.2.3 Sm-153
6.3.2.4 Re-186
6.3.2.5 Lu-177
6.3.2.6 Other Beta Emitters
6.3.3 Brachytherapy Isotopes
6.3.3.1 I-125
6.3.3.2 Ir-192
6.3.3.3 Pd-103
6.3.3.4 Cs-131
6.3.3.5 Other Brachytherapy Isotopes

7 Nuclear Medicine/Radiopharmaceuticals Market, By Application (Page No. – 87)
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 Spect Applications
7.2.1.1 Cardiology
7.2.1.2 Lymphoma
7.2.1.3 Neurology
7.2.1.4 Thyroid
7.2.1.5 Other Spect Applications
7.2.2 Pet Applications
7.2.2.1 Oncology
7.2.2.2 Cardiology
7.2.2.3 Neurology
7.2.2.4 Other Pet Applications
7.3 Therapeutic Applications
7.3.1 Thyroid
7.3.2 Bone Metastasis
7.3.3 Lymphoma
7.3.4 Endocrine Tumors
7.3.5 Other Therapeutic Applications

8 Nuclear Medicine/Radiopharmaceuticals Market, By Procedural Volume (Page No. – 103)
8.1 Introduction
8.2 Diagnostic Procedures
8.2.1 Spect Radiopharmaceuticals
8.2.2 Pet Radiopharmaceuticals
8.3 Therapeutic Procedures
8.3.1 Beta Emitters
8.3.2 Alpha Emitters
8.3.3 Brachytherapy Isotopes

9 Nuclear Medicine/Radiopharmaceuticals Market, By Region (Page No. – 112)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 RoE
9.4 Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 173)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Agreements, Partnerships, and Contracts
10.3.2 Product Approvals
10.3.3 Funding
10.3.4 Acquisitions
10.3.5 Expansions
10.3.6 Other Developments

11 Company Profiles (Page No. – 180)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Cardinal Health
11.2 Ge Healthcare (A Fully-Owned Subsidiary of General Electric Company)
11.3 Curium
11.4 Lantheus Medical Imaging
11.5 Bayer
11.6 Bracco Imaging
11.7 Eczacibasi-Monrol Nuclear Products
11.8 Nordion (A Subsidiary of Sterigenics International)
11.9 Advanced Accelerator Applications (Aaa, Acquired By Novartis)

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 203)
12.1 Discussion Guide
12.2 Introducing RT: Real-Time Market Intelligence
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (250 Tables)

Table 1 New Reactors Expected to Open During the Forecast Period
Table 2 Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 3 Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 4 Diagnostic Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 5 North America: Diagnostic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 6 Europe: Diagnostic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 7 Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 8 Spect Radiopharmaceuticals Market, By Region, 2016–2023 (USD Million)
Table 9 North America: Spect Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 10 Europe: Spect Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 11 Tc-99m Market, By Region, 2016–2023 (USD Million)
Table 12 North America: Tc-99m Market, By Country, 2016–2023 (USD Million)
Table 13 Europe: Tc-99m Market, By Country, 2016–2023 (USD Million)
Table 14 Tl-201 Market, By Region, 2016–2023 (USD Million)
Table 15 North America: Tl-201 Market, By Country, 2016–2023 (USD Million)
Table 16 Europe: Tl-201 Market, By Country, 2016–2023 (USD Million)
Table 17 Ga-67 Market, By Region, 2016–2023 (USD Million)
Table 18 North America: Ga-67 Market, By Country, 2016–2023 (USD Million)
Table 19 Europe: Ga-67 Market, By Country, 2016–2023 (USD Million)
Table 20 I-123 Market, By Region, 2016–2023 (USD Million)
Table 21 North America: I-123 Market, By Country, 2016–2023 (USD Million)
Table 22 Europe: I-123 Market, By Country, 2016–2023 (USD Million)
Table 23 Other Spect Isotopes Market, By Region, 2016–2023 (USD Million)
Table 24 North America: Other Spect Isotopes Market, By Country, 2016–2023 (USD Million)
Table 25 Europe: Other Spect Isotopes Market, By Country, 2016–2023 (USD Million)
Table 26 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 27 Pet Radiopharmaceuticals Market, By Region, 2016–2023 (USD Million)
Table 28 North America: Pet Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 29 Europe: Pet Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 30 F-18 Market, By Region, 2016–2023 (USD Million)
Table 31 North America: F-18 Market, By Country, 2016–2023 (USD Million)
Table 32 Europe: F-18 Market, By Country, 2016–2023 (USD Million)
Table 33 Ru-82 Market, By Region, 2016–2023 (USD Million)
Table 34 North America: Ru-82 Market, By Country, 2016–2023 (USD Million)
Table 35 Europe: Ru-82 Market, By Country, 2016–2023 (USD Million)
Table 36 Other Pet Isotopes Market, By Region, 2016–2023 (USD Million)
Table 37 North America: Other Pet Isotopes Market, By Country, 2016–2023 (USD Million)
Table 38 Europe: Other Pet Isotopes Market, By Country, 2016–2023 (USD Million)
Table 39 Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 40 Therapeutic Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 41 North America: Therapeutic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 42 Europe: Therapeutic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 43 Ra-223 Market, By Region, 2016–2023 (USD Million)
Table 44 North America: Ra-223 Market, By Country, 2016–2023 (USD Million)
Table 45 Europe: Ra-223 Market, By Country, 2016–2023 (USD Million)
Table 46 Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 47 Beta Emitters Market, By Region, 2016–2023 (USD Million)
Table 48 North America: Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 50 I-131 Market, By Region, 2016–2023 (USD Million)
Table 51 North America: I-131 Market, By Country, 2016–2023 (USD Million)
Table 52 Europe: I-131 Market, By Country, 2016–2023 (USD Million)
Table 53 Y-90 Market, By Region, 2016–2023 (USD Million)
Table 54 North America: Y-90 Market, By Country, 2016–2023 (USD Million)
Table 55 Europe: Y-90 Market, By Country, 2016–2023 (USD Million)
Table 56 Sm-153 Market, By Region, 2016–2023 (USD Million)
Table 57 North America: Sm-153 Market, By Country, 2016–2023 (USD Million)
Table 58 Europe: Sm-153 Market, By Country, 2016–2023 (USD Million)
Table 59 Re-186 Market, By Region, 2016–2023 (USD Million)
Table 60 North America: Re-186 Market, By Country, 2016–2023 (USD Million)
Table 61 Europe: Re-186 Market, By Country, 2016–2023 (USD Million)
Table 62 Lu-177 Market, By Region, 2016–2023 (USD Million)
Table 63 North America: Lu-177 Market, By Country, 2016–2023 (USD Million)
Table 64 Europe: Lu-177 Market, By Country, 2016–2023 (USD Million)
Table 65 Other Beta Emitters Market, By Region, 2016–2023 (USD Million)
Table 66 North America: Other Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 67 Europe: Other Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 68 Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 69 Brachytherapy Isotopes Market, By Region, 2016–2023 (USD Million)
Table 70 North America: Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 71 Europe: Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 72 I-125 Market, By Region, 2016–2023 (USD Million)
Table 73 North America: Iodine-125 Market, By Country, 2016–2023 (USD Million)
Table 74 Europe: Iodine-125 Market, By Country, 2016–2023 (USD Million)
Table 75 Ir-192 Market, By Region, 2016–2023 (USD Million)
Table 76 North America: Ir-192 Market, By Country, 2016–2023 (USD Million)
Table 77 Europe: Ir-192 Market, By Country, 2016–2023 (USD Million)
Table 78 Pd-103 Market, By Region, 2016–2023 (USD Million)
Table 79 North America: Pd-103 Market, By Country, 2016–2023 (USD Million)
Table 80 Europe: Pd-103 Market, By Country, 2016–2023 (USD Million)
Table 81 Cs-131 Market, By Region, 2016–2023 (USD Million)
Table 82 North America: Cs-131 Market, By Country, 2016–2023 (USD Million)
Table 83 Europe: Cs-131 Market, By Country, 2016–2023 (USD Million)
Table 84 Other Brachytherapy Isotopes Market, By Region, 2016–2023 (USD Million)
Table 85 North America: Other Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 86 Europe: Other Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 87 Spect Applications Market, By Type, 2016–2023 (USD Million)
Table 88 Spect Applications Market, By Region, 2016–2023 (USD Million)
Table 89 Cardiology Applications Market, By Region, 2016–2023 (USD Million)
Table 90 Lymphoma Applications Market, By Region, 2016–2023 (USD Million)
Table 91 Neurology Applications Market, By Region, 2016–2023 (USD Million)
Table 92 Thyroid Applications Market, By Region, 2016–2023 (USD Million)
Table 93 Other Spect Applications Market, By Region, 2016–2023 (USD Million)
Table 94 Pet Applications Market, By Type, 2016–2023 (USD Million)
Table 95 Pet Applications Market, By Region, 2016–2023 (USD Million)
Table 96 Oncology Applications Market, By Region, 2016–2023 (USD Million)
Table 97 Cardiology Applications Market, By Region, 2016–2023 (USD Million)
Table 98 Neurology Applications Market, By Region, 2016–2023 (USD Million)
Table 99 Other Pet Applications Market, By Region, 2016–2023 (USD Million)
Table 100 Therapeutic Applications Market, By Type, 2016–2023 (USD Million)
Table 101 Therapeutic Applications Market, By Region, 2016–2023 (USD Million)
Table 102 Thyroid Applications Market, By Region, 2016–2023 (USD Million)
Table 103 Bone Metastasis Applications Market, By Region, 2016–2023 (USD Million)
Table 104 Lymphoma Applications Market, By Region, 2016–2023 (USD Million)
Table 105 Endocrine Applications Market, By Region, 2016–2023 (USD Million)
Table 106 Other Therapeutic Applications Market, By Region, 2016–2023 (USD Million)
Table 107 Nuclear Medicine Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 108 Nuclear Medicine Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 109 Diagnostic Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 110 Diagnostic Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 111 Spect Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 112 Spect Radiopharmaceuticals Market, By Type, By Region, 2016–2023 (Thousand Procedures)
Table 113 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 114 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 115 Therapeutic Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 116 Therapeutic Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 117 Beta Emitters Market, By Type, 2016–2023 (Thousand Procedures)
Table 118 Beta Emitters Market, By Region, 2016–2023 (Thousand Procedures)
Table 119 Alpha Emitters Market, By Region, 2016–2023 (Thousand Procedures)
Table 120 Brachytherapy Isotopes Market, By Type, 2016–2023 (Thousand Procedures)
Table 121 Brachytherapy Isotopes Market, By Region, 2016–2023 (Thousand Procedures)
Table 122 Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 123 North America: Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 124 North America: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 125 North America: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 126 North America: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 127 North America: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 128 North America: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 129 North America: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 130 North America: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 131 North America: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 132 North America: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 133 North America: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 134 US: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 135 US: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 136 US: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 137 US: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 138 US: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 139 US: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 140 US: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 141 US: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 142 US: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 143 US: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 144 Canada: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 145 Canada: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 146 Canada: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 147 Canada: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 148 Canada: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 149 Canada: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 150 Canada: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 151 Canada: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 152 Canada: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 153 Canada: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 154 Europe: Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 155 Europe: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 156 Europe: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 157 Europe: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 158 Europe: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 159 Europe: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 160 Europe: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 161 Europe: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 162 Europe: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 163 Europe: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 164 Europe: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 165 Germany: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 166 Germany: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 167 Germany: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 168 Germany: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 169 Germany: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 170 Germany: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 171 Germany: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 172 Germany: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 173 Germany: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 174 Germany: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 175 France: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 176 France: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 177 France: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 178 France: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 179 France: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 180 France: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 181 France: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 182 France: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 183 France: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 184 France: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 185 UK: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 186 UK: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 187 UK: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 188 UK: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 189 UK: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 190 UK: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 191 UK: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 192 UK: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 193 UK: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 194 UK: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 195 Italy: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 196 Italy: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 197 Italy: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 198 Italy: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 199 Italy: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 200 Italy: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 201 Italy: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 202 Italy: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 203 Italy: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 204 Italy: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 205 Spain: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 206 Spain: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 207 Spain: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 208 Spain: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 209 Spain: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 210 Spain: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 211 Spain: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 212 Spain: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 213 Spain: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 214 Spain: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 215 RoE: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 216 RoE: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 217 RoE: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 218 RoE: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 219 RoE: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 220 RoE: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 221 RoE: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 222 RoE: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 223 RoE: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 224 RoE: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 225 Asia Pacific: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 226 Asia Pacific: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 227 Asia Pacific: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 228 Asia Pacific: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 229 Asia Pacific: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 230 Asia Pacific: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 231 Asia Pacific: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 232 Asia Pacific: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 233 Asia Pacific: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 234 Asia Pacific: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 235 RoW: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 236 RoW: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 237 RoW: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 238 RoW: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 239 RoW: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 240 RoW: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 241 RoW: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 242 RoW: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 243 RoW: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 244 RoW: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 245 Agreements, Partnerships, and Contracts (2015–2018)
Table 246 Product Approvals (2015–2018)
Table 247 Funding (2015–2018)
Table 248 Acquisitions (2015–2018)
Table 249 Expansions (2015–2018)
Table 250 Other Developments (2015–2018)

List of Figures (34 Figures)

Figure 1 Global Nuclear Medicine Market: Research Methodology
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Nuclear Medicine Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Nuclear Medicine Market for Spect Applications, By Type, 2018 vs 2023 (USD Million)
Figure 9 Nuclear Medicine Market for Pet Applications, By Type, 2018 vs 2023 (USD Million)
Figure 10 Rising Incidence & Prevalence of Cancer & Cardiovascular Diseases—Key Factor Supporting Market Growth During the Forecast Period
Figure 11 Oncology Segment Dominated the Nuclear Medicine Market for Pet Applications in 2017
Figure 12 Diagnostics Segment Will Continue to Dominate the Nuclear Medicine Market in 2023
Figure 13 Asia Pacific to Witness the Highest Growth in the Nuclear Medicine Market During the Forecast Period
Figure 14 Drivers, Restraints, Opportunities, and Challenges
Figure 15 Diagnostic Nuclear Medicine Segment Commanded the Largest Share of the Nuclear Medicine Market in 2017
Figure 16 Pet Radiopharmaceuticals to Register the Highest Growth Rate During the Forecast Period
Figure 17 Alpha Emitters Will Continue to Dominate the Therapeutic Nuclear Medicine Market During the Forecast Period
Figure 18 Geographical Snapshot of the Nuclear Medicine Market
Figure 19 Thyroid Segment is Expected to Register the Highest CAGR in the Spect Applications Market During the Forecast Period
Figure 20 Oncology Applications Segment is Expected to Grow at the Highest CAGR in the Pet Applications Market During the Forecast Period
Figure 21 Endocrine Tumors Application Segment is Expected to Register the Highest CAGR in the Therapeutic Applications Market During the Forecast Period
Figure 22 Nuclear Medicine Procedures Market, By Type, 2018 vs 2023 (Thousand Procedures)
Figure 23 North America to Dominate the Nuclear Medicine Market in 2018
Figure 24 North America: Nuclear Medicine Market Snapshot
Figure 25 Europe: Nuclear Medicine Market Snapshot
Figure 26 Asia Pacific: Nuclear Medicine Market Snapshot
Figure 27 RoW: Nuclear Medicine Market Snapshot
Figure 28 Key Developments in the Nuclear Medicine Market, 2015–2018
Figure 29 Market Share Analysis, By Key Players, 2017
Figure 30 Cardinal Health: Company Snapshot (2017)
Figure 31 GE Healthcare: Company Snapshot (2017)
Figure 32 Lantheus Medical Imaging: Company Snapshot (2017)
Figure 33 Bayer: Company Snapshot (2017)
Figure 34 Advanced Accelerator Applications: Company Snapshot (2016)



【レポートのキーワード】

核医学、放射性医薬品

★調査レポート[核医学/放射性医薬品の世界市場予測（～2023年）] (コード：PH-3590)販売に関する免責事項を必ずご確認ください。
★調査レポート[核医学/放射性医薬品の世界市場予測（～2023年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 試験管内肺モデルの世界市場予測（～2023年）
    BT6203 / MarketsandMarkets / 2018年4月25日 / MarketsandMarketsが発行した当調査レポートでは、試験管内肺モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（2D、3D）別分析、用途別分析、地域別分析、試験管内肺モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in cell culture technologies, and the development of new 3D in vitro models. The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house...
  • 核酸分離・浄化の世界市場予測（～2023年）
    BT-2398 / MarketsandMarkets / 2018年6月15日 / MarketsandMarketsが発行した当調査レポートでは、核酸分離・浄化の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、キット、装置）別分析、方法別分析、タイプ別分析、用途別分析、核酸分離・浄化の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global nucleic acid isolation and purification market is expected to reach USD 4.38 billion by 2023 from USD 2.77 billion in 2018, at a CAGR of 9.6%. The major factors driving the growth of the market include increasing public-private funding for life science research, technological advancements, and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market. This report segments the nucleic acid isolation and purification market into product, method, type, application, end user, and region. On the basis of product, the market is segmented into instruments, kits, and reagents. In...
  • 初代細胞の世界市場予測（～2023年）：造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉
    BT6489 / MarketsandMarkets / 2018年7月31日 / MarketsandMarketsが発行した当調査レポートでは、初代細胞の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別（ヒト、動物）分析、由来別（造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉）分析、エンドユーザー別（ライフサイエンス研究、研究機関）分析、初代細胞の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing. The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung,...
  • 神経科学用抗体＆アッセイの世界市場予測（～2023年）
    BT6283 / MarketsandMarkets / 2018年5月16日 / MarketsandMarketsが発行した当調査レポートでは、神経科学用抗体＆アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、装置）別分析、技術別分析、用途別分析、需要先別分析、神経科学用抗体＆アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. This report segments the neuroscience antibodies and assays market into product, technology, application, end user, and region. Based on product, the neuroscience antibodies and assays market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to...
  • 幹細胞バンキングの世界市場予測（～2023年）
    BT4447 / MarketsandMarkets / 2018年5月15日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞バンキングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソース別分析、サービス種類別分析、用途別分析、地域別分析、幹細胞バンキングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%. Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market. This report broadly categorizes the global stem cell banking market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into...
  • クレアチニン測定の世界市場予測（～2023年）：キット、試薬
    BT-6361 / MarketsandMarkets / 2018年6月11日 / MarketsandMarketsが発行した当調査レポートでは、クレアチニン測定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（キット、試薬）別分析、テスト種類別分析、サンプル別分析、需要先別分析、クレアチニン測定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type,...
  • 遺伝子パネルの世界市場予測（～2023年）
    BT6318 / MarketsandMarkets / 2018年5月29日 / MarketsandMarketsが発行した当調査レポートでは、遺伝子パネルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス別分析、技術（アンプリコン、ハイブリダイゼーション）別分析、デザイン別分析、用途別分析、遺伝子パネルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%. The growth of this market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panels owing to the benefits they offer. This report segments the gene panels market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2018, the test kits segment accounted for the largest share of...
  • トランスファーメンブレンの世界市場予測（～2023年）：PVDF、ニトロセルロース、ナイロン
    BT-6377 / MarketsandMarkets / 2018年6月15日 / MarketsandMarketsが発行した当調査レポートでは、トランスファーメンブレンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（PVDF、ニトロセルロース、ナイロン）別分析、トランスファー方法別分析、用途別分析、需要先別分析、トランスファーメンブレンの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of transfer membrane market. The report analyzes the global transfer membrane market by type, transfer method, application, end user, and region. On the basis of type, the transfer membrane market is divided into nylon...
  • 医療用エクソスケルトンの世界市場予測（～2023年）
    MD6481 / MarketsandMarkets / 2018年7月26日 / MarketsandMarketsが発行した当調査レポートでは、医療用エクソスケルトンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、コンポーネント別（ハードウェア、ソフトウェア）分析、タイプ別（動力式、パッシブ）分析、四肢別（下肢、上肢）分析、モビリティ別（移動型、据置型）分析、医療用エクソスケルトンの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 116.7 million in 2018, at a CAGR of 37.4% during the forecast period. Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches and increasing insurance coverage for medical exoskeletons in several countries are driving the growth of the medical exoskeleton market. The report segments the market into component, type, mobility, extremity, and region. By extremity, the market is segmented into lower extremity medical exoskeletons and upper extremity medical exoskeletons. The upper extremity...
  • マルチプレックスアッセイの世界市場予測（～2023年）
    BT-4473 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、装置）別分析、種類別分析、技術別分析、用途（研究開発、診断）別分析、マルチプレックスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the multiplex assays...

    • ◆H&Iグローバルリサーチのお客様（例）◆